ATLASKiora Pharmaceuticals (KPRX) Q3 2026 earnings results
Kiora Pharmaceuticals (KPRX) reported EPS of -$0.28 against an analyst estimate of -$0.38: a beat of $0.10 (26.3%). The quarter ended Sep 30, 2026; the company reported on Friday, November 13, 2026.
Status: Confirmed · 10:12 ET, Nov 13 · Source: EODHD (calendar and fundamentals, cross-checked)
Get an email before and after Kiora Pharmaceuticals reports, free with your ATLAS account
Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.
Create free accountKPRX Q3 2026 results at a glance
| EPS reported | -$0.28 |
|---|---|
| EPS estimate | -$0.38 |
| Surprise | Beat · +$0.10 (+26.3%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Nov 13, 2026 |
| Status | Confirmed · 10:12 ET, Nov 13 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is Kiora Pharmaceuticals’s Q3 2026, a calendar-year company.
Kiora Pharmaceuticals EPS surprise history: last 5 quarters
Kiora Pharmaceuticals beat the EPS estimate in 4 of its last 5 reports, with an average surprise of +35.4%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Nov 13, 2026 | -$0.38 | -$0.28 | +26.3% | Beat | – |
| Aug 7, 2026 | -$0.62 | -$0.34 | +45.2% | Beat | +0.8% |
| May 8, 2026 | -$0.71 | -$0.58 | +18.3% | Beat | -1.6% |
| Jan 30, 2026 | $0.42 | $0.36 | -14.3% | Miss | +1.7% |
| Nov 7, 2025 | -$0.72 | $0.01 | +101.4% | Beat | +0.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
KPRX stock reaction to the report
The price reaction will be added after the Nov 16, 2026 close.
This section appears once a post-report closing price exists and updates with every new close.
Next KPRX earnings report
Kiora Pharmaceuticals has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the KPRX earnings calendar.
ATLAS fair value and signal for KPRX
| Last price | $1.25 (-6.0%) |
|---|---|
| Chance of a higher close in 1 month | 44% (normal range $1.00–$1.44) |
These are model outputs from the same valuation and calibrated model as the Kiora Pharmaceuticals stock page. They describe an ordinary period and are not a forecast of any particular outcome.
Kiora Pharmaceuticals Q3 2026 earnings: frequently asked questions
Did Kiora Pharmaceuticals beat earnings estimates for Q3 2026?
Kiora Pharmaceuticals reported EPS of -$0.28 against an analyst estimate of -$0.38: a beat of $0.10 (26.3%).
When did Kiora Pharmaceuticals report Q3 2026 results?
Kiora Pharmaceuticals reported on Friday, November 13, 2026, for the quarter ended Wednesday, September 30, 2026.
How often does KPRX beat EPS estimates?
In its last 5 reports with a recorded result, Kiora Pharmaceuticals beat the EPS estimate 4 times; the average surprise was +35.4%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer